Weill Medical College of Cornell University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Weill Medical College of Cornell University sits in the top decile of US sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count).
Weill Medical College of Cornell University: 701 sponsored US clinical trials, 127 recruiting.
Weill Medical College of Cornell University sponsors 701 registered US clinical trials on ClinicalTrials.gov, 127 of them currently recruiting, and 387 completed. 89 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 20 trials.
Top-decile sponsor footprint
Weill Medical College of Cornell University ranks in the top decile of sponsors by registered trial count (#49 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
387 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
701 total, page 5 of 15
HCV Test and Treat Utilizing Simplified HCV Patient Education
NCT05582681
Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia
NCT05544734
Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial
NCT05293106
The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery-Extended Follow-Up
NCT05903222
The Effect of Simulation-based Training on Confidence and Competence in Obtaining Vitals in a Child With Autism
NCT05288868
Leveraging Home Health Aides to Improve Outcomes in Heart Failure
NCT04239911
The Feasibility of Engage Therapy With Video Support for Homebound Older Adults
NCT05346055
Patient Experiences With Virtual Reality Mindfulness Skills Training
NCT05291533
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
NCT05170009
A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors
NCT05136092
Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice
NCT04243538
Virtual Reality in Laryngology
NCT05218967
Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
NCT04843579
COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes
NCT05119400
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
NCT04925947
Implementing a Family Caregiver Checklist in Primary Care: A Pilot Study
NCT04946942
Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis
NCT04964297
Positive Affect as a Source of Resilience for Adults in Chronic Pain
NCT04869345
Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics
NCT05062460
Improving Cognitive Health in COVID-19 Survivors
NCT04843930
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer
NCT04951115
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2
NCT04815876
Mobile Cognitive Behavior Therapy Targeting Anxiety Disorders
NCT05130281
A Prospective Trial on Nerve Sparing Techniques Performed in Radical Prostatectomy
NCT04393831
Evaluation of a Remote Asthma Monitoring Program to Improve Health Outcomes in Pediatric Asthma
NCT05139485
Developing and Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms and Caregiver Burden in Home Hospice. Phase 1.
NCT04074304
Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment
NCT04890314
Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
NCT04685499
Adaptation of Ca-HELP Intervention in Rural Geriatric Cancer Patient Population
NCT04262232
The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring
NCT04738799
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
NCT04757584
Impact of Beta-blockers on Physical Function in HFpEF
NCT04767061
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy
NCT04843566
Comparative Effectiveness of Telemedicine in Primary Care
NCT04684836
Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome
NCT04941807
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
NCT04631744
pCHIP: Prostate Cancer Health Impact Program
NCT04293406
Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy
NCT04149821
Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients
NCT04672161
Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
NCT04488497
Rimegepant in Moderate Plaque-type Psoriasis
NCT04629950
COVID-19 Respiratory Outcomes Registry
NCT05074875
The Impact of Time Restricted Feeding in Crohn's Disease
NCT04271748
Cognitive Training in Stroke Rehabilitation
NCT04472351
Naltrexone Treatment for Prolonged Grief Disorder (PGD)
NCT04547985
Telehealth Language Intervention for Children With Autism Ages 2-4 Years
NCT04675580
Evaluation of PSMA Antagonist Produced by Two Different Methods
NCT04685811
Hypertension, Brain Clearance, and Markers of Neurodegeneration
NCT05785871
Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant
NCT04530630
After Cesarean Time Interval for Exercise (ACTIVE) Trial
NCT04345757
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 111 |
| Phase 3 | 26 |
| Phase 4 | 63 |
Therapeutic Areas
What is open in the Weill Medical College of Cornell University pipeline
127 recruiting of 701 indexed (18% open); 387 completed (55%).
Phase mix: 89 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Weill Medical College of Cornell University: open-pipeline peers nationwide
Peers matched on 701 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Weill Medical College of Cornell University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 701 trials (± recruiting share)
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Sanofi · 713 trials · 10% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
Related
What to do with this Weill Medical College of Cornell University page
701 registered trials is a research-attention snapshot, not an endorsement of Weill Medical College of Cornell University or any single study.
- 127 of Weill Medical College of Cornell University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Weill Medical College of Cornell University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Weill Medical College of Cornell University pipeline card: 701 registered trials from official public datasets.Report a data error.